Skip to content

Clinical trials

Active, not recruiting Neurocognitive Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurocognitive Disorders Status: Active, not recruiting Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20191
20211
20224
20234
20245
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Haseki Training and Research Hospital2
AO GENERIUM1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
AskBio France, SAS, a subsidiary of AskBio Inc.1
Brigham and Women's Hospital1
Centre Hospitalier Universitaire de Nice1
EIP Pharma Inc1
GLORIA FIORAVANTI1
Jewish General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurocognitive Disorders17
Cognitive Dysfunction8
Nervous System Diseases6
Alzheimer Disease5
Brain Diseases5
Central Nervous System Diseases5
Mental Disorders5
Neurodegenerative Diseases5
Cognition Disorders3
Dementia3

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.